182
Views
1
CrossRef citations to date
0
Altmetric
Original Research

A Functional Respiratory Imaging Approach to the Effect of an Oscillating Positive Expiratory Pressure Device in Chronic Obstructive Pulmonary Disease

ORCID Icon, , ORCID Icon, , , , ORCID Icon & ORCID Icon show all
Pages 1261-1268 | Published online: 04 Jun 2020

References

  • RamosFL, KrahnkeJS, KimV. Clinical issues of mucus accumulation in COPD. Int J COPD. 2014;9:139–150.
  • VolskoT. Airway clearance therapy: finding the evidence. Respir Care. 2013;58(10):1669–1678. doi:10.4187/respcare.0259024064626
  • OsadnikCR, McDonaldCF, HollandAE. Airway clearance techniques for chronic obstructive pulmonary disease. Expert Rev Respir Med. 2013;7(6):673–685. doi:10.1586/17476348.2013.84736824224510
  • PrescottE, LangeP, VestboJ. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J. 1995;8(8):1333–1338. doi:10.1183/09031936.95.080813337489800
  • OsadnikCR, McDonaldCF, HollandAE, RamosFL, KrahnkeJS, KimV. Clinical issues of mucus accumulation in COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:139–150. doi:10.2147/COPD.S3893824493923
  • IdesK, VissersD, VissersD, De BackerL, LeemansG, De BackerW. Airway clearance in COPD: need for a breath of fresh air? A systematic review. COPD. 2011;8(3):196–205. doi:10.3109/15412555.2011.56058221513439
  • SvenningsenS, PaulinGA, SheikhK, et al. Oscillatory positive expiratory pressure in chronic obstructive pulmonary disease. COPD. 2016;13(1):66–74. doi:10.3109/15412555.2015.104352326430763
  • SuggettJ. Quality of Life (QOL) responder rate analysis following use of an Oscillating Positive Expiratory Pressure (OPEP) device for Chronic Obstructive Pulmonary Disease (COPD): SGRQV CAT assessments - abstract presentations, COPD10, Birmingham, United Kingdom. Chronic Obs Pulm Dis. 2017;4(3):225–246.
  • BurudpakdeeC, SeetasithA, DunneP, et al. A real-world study of 30-day exacerbation outcomes in chronic obstructive pulmonary disease (COPD) patients managed with aerobika OPEP. Pulm Ther. 2017;3(1):163–171. doi:10.1007/s41030-017-0027-5
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease - 2019 Report. Glob Initiat Chronic Obstr Lung Dis Inc; 2019.
  • De BackerJW, VosWG, VinchurkarSC, et al. Validation of computational fluid dynamics in CT-based airway models with SPECT/CT. Radiology. 2010;257(3):854–862. doi:10.1148/radiol.1010032221084417
  • BatesD, MächlerM, BolkerBM, WalkerSC. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1). doi:10.18637/jss.v067.i01
  • KollerM, StahelWA. Sharpening Wald-type inference in robust regression for small samples. Comput Stat Data Anal. 2011;55(8):2504–2515. doi:10.1016/j.csda.2011.02.014
  • De BackerJ, VosW, VinchurkarS, et al. The effects of extrafine beclometasone/formoterol (BDP/F) on lung function, dyspnea, hyperinflation, and airway geometry in COPD patients: novel insight using functional respiratory imaging. J Aerosol Med Pulm Drug Deliv. 2014;27:1–12. doi:10.1089/jamp.2013.104924252061
  • VosW, Backer DeJ, PoliG, et al. Novel functional imaging of changes in small airways of patients treated with extrafine beclomethasone/formoterol. Respiration. 2013;86(5):393–401. doi:10.1159/00034712023595105
  • De BackerW, VosW, Van HolsbekeC, et al. The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients. Eur Respir J. 2014;44(2):527–529. doi:10.1183/09031936.0001171424791831
  • VosW, HajianB, De BackerJ, et al. Functional respiratory imaging to assess the interaction between systemic roflumilast and inhaled ICS/LABA/LAMA. Int J Chron Obstruct Pulmon Dis. 2016;11:263–271. doi:10.2147/COPD.S9383026917956
  • KimY, SchroederJ, LynchD, et al. Gender differences of airway dimensions in anatomically matched sites on CT in smokers. COPD J Chronic Obstr Pulm Dis. 2011;8(4):285–292. doi:10.3109/15412555.2011.586658
  • KimCS, HuSC. Regional deposition of inhaled particles in human lungs; comparison between men and women. J Appl Physiol. 1998;84(6):1834–1844. doi:10.1152/jappl.1998.84.6.18349609774
  • SvenningsenS, GuoF, McCormackDG, ParragaG. Noncystic fibrosis bronchiectasis: regional abnormalities and response to airway clearance therapy using pulmonary functional magnetic resonance imaging. Acad Radiol. 2017;24(1):4–12. doi:10.1016/j.acra.2016.08.02127717759
  • Rodriguez HortalMC, HjelteL. Time point to perform lung function tests evaluating the effects of an airway clearance therapy session in cystic fibrosis. Respir Care. 2014;59(10):1537–1541. doi:10.4187/respcare.0282324847094
  • IdesK, VosW, De BackerL, et al. Acute effects of intrapulmonary percussive ventilation in COPD patients assessed by using conventional outcome parameters and a novel computational fluid dynamics technique. Int J Chron Obstruct Pulmon Dis. 2012;7:667–671. doi:10.2147/COPD.S2984723055715